New weapons to fight a new enemy: A systematic review of drug combinations against the drug‐resistant fungus Candida auris

In vitro Evaluation of Antifungal Drug Combinations against Multidrug-resistant Candida auris isolates from New York Outbreak

(2020) Brittany O'Brien et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Identification of off-patent drugs that show synergism with Amphotericin B or that present antifungal action against Cryptococcus neoformans and Candida spp.

(2020) Suélen Andreia Rossi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin interacts synergistically with echinocandins against Candida auris

(2020) A.L. Bidaud et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris

(2020) Siham Shaban et al.   Scientific Reports

Antifungal evaluation of traditional herbal monomers and their potential for inducing cell wall remodeling in Candida albicans and Candida auris

(2020) Juanjuan Liu et al.   BIOFOULING

Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species

(2020) Hassan E. Eldesouky et al.   Scientific Reports

Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities

(2020) Hassan E. Eldesouky et al.   Scientific Reports

Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections

(2020) Morgan A Wambaugh et al.   eLife

Antifungal Activity and Mode of Action of Miltefosine Against Clinical Isolates of Candida krusei

(2020) Yongqin Wu et al.   Frontiers in Microbiology

In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris

(2020) Fruzsina Nagy et al.   Frontiers in Microbiology

Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic Candida Species

(2020) Nicole M. Revie et al.   mSphere

Combination of miconazole and domiphen bromide is fungicidal against biofilms of resistant Candida spp.

(2020) Jana Tits et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris

(2020) Thayná Lopes Barreto et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Palindromic Peptide LfcinB (21‐25) Pal Exhibited Antifungal Activity against Multidrug‐Resistant Candida

(2020) Yerly Vargas‐Casanova et al.   ChemistrySelect

Farnesol increases the activity of echinocandins against Candida auris biofilms

(2019) Fruzsina Nagy et al.   MEDICAL MYCOLOGY

Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris

(2019) Haroldo Cesar de Oliveira et al.   Frontiers in Cellular and Infection Microbiology

In vitro polymyxin activity against clinical multidrug-resistant fungi

(2019) Hanane Yousfi et al.   Antimicrobial Resistance and Infection Control

Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris

(2019) Ryan Kean et al.   mSphere

In Vitro Interaction of Geldanamycin with Triazoles and Echinocandins Against Common and Emerging Candida Species

(2019) Shahram Mahmoudi et al.   MYCOPATHOLOGIA

In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism

(2019) A. L. Bidaud et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Antifungal Susceptibility of the Emerging Multidrug-Resistant Pathogen Candida auris to Miltefosine Alone and in Combination with Amphotericin B

(2019) Yongqin Wu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as Determined by EUCAST Methodology and Comparison with Activity against C. albicans and C. glabrata and with the Activities of Six Comparator Agents

(2019) Maiken Cavling Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model

(2018) Christopher L Hager et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacodynamic Evaluation of Rezafungin (CD101) Against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model

(2018) Alexander J. Lepak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development

(2018) Gina Wall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris

(2018) Hassan E. Eldesouky et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options

(2018) Janaina de Cássia Orlandi Sardi et al.   MICROBIAL PATHOGENESIS

Seroepidemiological investigation of HAdV-4 infection among healthy adults in China and in Sierra Leone, West Africa

(2018) Busen Wang et al.   Emerging Microbes & Infections

Antifungal activity of tyrosol and farnesol used in combination against Candida species in the planktonic state or forming biofilms

(2017) D.R. Monteiro et al.   JOURNAL OF APPLIED MICROBIOLOGY

Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface

(2017) Rory M. Welsh et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins

(2017) Andrew M. Borman et al.   MEDICAL MYCOLOGY

Calli Essential Oils Synergize with Lawsone against Multidrug Resistant Pathogens

(2017) Sameh Soliman et al.   MOLECULES

Current perspective on emergence, diagnosis and drug resistance in Candida auris

(2017) Smita Sarma et al.   Infection and Drug Resistance

Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

(2016) Shawn R. Lockhart et al.   CLINICAL INFECTIOUS DISEASES

Miltefosine inhibits Candida albicans and non- albicans Candida spp. biofilms and impairs the dispersion of infectious cells

(2016) Taissa Vila et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In VitroActivity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions andIn VivoEfficacy in a Murine Model of Oral Candidiasis

(2015) Taissa Vieira Machado Vila et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic combinations of antifungals and anti-virulence agents to fight againstCandida albicans

(2015) Jinhui Cui et al.   Virulence

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Synergy of the antibiotic colistin with echinocandin antifungals in Candida species

(2013) U. Zeidler et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antifungal Activity of Geldanamycin Alone or in Combination with Fluconazole Against Candida species

(2013) Jinqing Zhang et al.   MYCOPATHOLOGIA

In VitroInteractions between Aspirin and Amphotericin B against Planktonic Cells and Biofilm Cells of Candida albicans and C. parapsilosis

(2012) Yabin Zhou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris

(2011) Wee Gyo Lee et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital

(2009) Kazuo Satoh et al.   MICROBIOLOGY AND IMMUNOLOGY